Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...

Metabolic dysfunction-associated steatotic liver disease, or MASLD, is an umbrella term describing conditions related to a ...

Dubai: At Arab Health 2025 in Dubai, Emirates Health Services (EHS) is showcasing initiatives advancing heart and diabetes treatments. The first project is the Total Artificial Heart (TAH), developed ...

Mounjaro can cause mild to moderate side effects, such as nausea, vomiting, constipation, and indigestion. According to Eli ...

Beta Bionics, Inc. (BBNX) is planning to raise $112 million in an initial public offering on Thursday, January 30th, IPO Scoop reports. The company will be issuing 7,500,000 shares at $14.00-$16.00 ...

President Donald Trump’s early action on health care reversed some of his predecessor’s policies, but former President Joe ...

A new formulation for medicine that does not need cold chain support, new air cargo friendly ultra-cold storage, and the FDA ...

The final proposed model would have had Medicare pay less for drugs that receive accelerated approvals from the Food and Drug ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is behind the schedule he announced ...

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.